Weight-of-evidence evaluation of long-term ozone exposure and cardiovascular effects

Critical Reviews in Toxicology

Volumn 44, Issue 9, 2014, Pages 791-822

  Prueitt, Robyn L ^a   Lynch, Heather N ^a   Zu, Ke ^a   Sax, Sonja N ^a   Venditti, Ferdinand J ^b   Goodman, Julie E ^a  

^a GRADIENT   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Air pollution; Cardiovascular system; Causal framework; Epidemiology; Mode of action; Risk assessment; Systematic review; Weight of evidence

Indexed keywords

OZONE; AIR POLLUTANT;

ADOLESCENT; ADULT; AGED; AIR QUALITY STANDARD; AMBIENT AIR; ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GOVERNMENT; HUMAN; IN VIVO STUDY; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUSE; NONHUMAN; RAT; REVIEW; WEIGHT OF EVIDENCE ANALYSIS; ADVERSE EFFECTS; AIR POLLUTANT; AIR POLLUTION; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; ENVIRONMENTAL EXPOSURE; META ANALYSIS; PROCEDURES; RISK ASSESSMENT; TOXICITY TESTING;

ANIMALIA;

AIR POLLUTANTS; AIR POLLUTION; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; HUMANS; OZONE; RISK ASSESSMENT; TOXICITY TESTS, CHRONIC;

EID: 84925241844     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2014.937855     Document Type: Review

References (79)

1. Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence Beeson W, Yang JX. (1999). Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med, 159, 373-82.
2. Atkinson RW, Carey IM, Kent AJ, van Staa TP, Anderson HR, Cook DG. (2013). Long-term exposure to outdoor air pollution and incidence of cardiovascular diseases. Epidemiology, 24, 44-53.
3. Barath S, Langrish JP, Lundback M, Bosson JA, Goudie C, Newby DE, et al. (2013). Short-term exposure to ozone does not impair vascular function or affect heart rate variability in healthy young men. Toxicol Sci, 135, 292-9.
4. Beckerman BS, Jerrett M, Finkelstein M, Kanaroglou P, Brook JR, Arain MA, et al. (2012). The association between chronic exposure to traffic-related air pollution and ischemic heart disease. J Toxicol Environ Health A, 75, 402-11.
5. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. (2008). False-positive results in cancer epidemiology: A plea for epistemological modesty. J Natl Cancer Inst, 100, 988-95.
6. Breton CV, Wang X, Mack WJ, Berhane K, Lopez M, Islam TS, et al. (2012). Childhood air pollutant exposure and carotid artery intimamedia thickness in young adults. Circulation, 126, 1614-20.
7. Carey IM, Atkinson RW, Kent AJ, van Staa T, Cook DG, Anderson HR. (2013). Mortality associations with long-term exposure to outdoor air pollution in a national English cohort. Am J Respir Crit Care Med, 187, 1226-33.
8. Carter WPL, Seinfeld JH. (2012). Winter ozone formation and VOC incremental reactivities in the Upper Green River Basin of Wyoming. Atmos Environ, 50, 255-66.
9. Centers for Disease Control (CDC). (1999). Physical Activity and Health: A Report of the Surgeon General, 1996. [Online] Available at http://www.cdc.gov/nccdphp/sgr/sgr.htm [Accessed on 21 May 2014].
10. Chen C, Arjomandi M, Balmes J, Tager I, Holland N. (2007). Effects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults. Environ Health Perspect, 115, 1732-7.
11. Chen LH, Knutsen SF, Shavlik D, Beeson WL, Petersen F, Ghamsary M, Abbey D. (2005). The association between fatal coronary heart disease and ambient particulate air pollution: Are females at greater risk? Environ Health Perspect, 113, 1723-9.
12. Chuang GC, Yang Z, Westbrook DG, Pompilius M, Ballinger CA, White CR, et al. (2009). Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am J Physiol Lung Cell Mol Physiol, 297, L209-L216.
13. Chuang KJ, Yan YH, Cheng TJ. (2010). Effect of air pollution on blood pressure, blood lipids, and blood sugar: A population-based approach. J Occup Environ Med, 52, 258-62.
14. Chuang KJ, Yan YH, Chiu SY, Cheng TJ. (2011). Long-term air pollution exposure and risk factors for cardiovascular diseases among the elderly in Taiwan. Occup Environ Med, 68, 64-8.
15. Doggrell SA, Brown L. (1998). Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res, 39, 89-105.
16. Dong GH, Qian Z, Wang J, Chen W, Ma W, Trevathan E, et al. (2013b). Associations between ambient air pollution and prevalence of stroke and cardiovascular diseases in 33 Chinese communities. Atmos Environ, 77, 968-73.
17. Dong GH, Qian ZM, Xaverius PK, Trevathan E, Maalouf S, Parker J, et al. (2013a). Association between long-term air pollution and increased blood pressure and hypertension in China. Hypertension, 61, 578-84.
18. Dorato MA, Wolff RK. (1991). Inhalation exposure technology, dosimetry, and regulatory issues. Toxicol Pathol, 19(4 Part 1), 373-83.
19. Droogmans S, Lauwers R, Cosyns B, Roosens B, Franken PR, Weytjens C, et al. (2008). Impact of anesthesia on valvular function in normal rats during echocardiography. Ultrasound Med Biol, 34, 1564-72.
20. Eskesen K, Olsen NT, Dimaano VL, Pinheiro A, Sogaard P, Fritz-Hansen T, et al. (2012). New approach to intracardiac hemodynamic measurements in small animals: Echo-guided percutaneous apical puncture. J Ultrasound Med, 31, 1233-8.
21. Forbes LJ, Patel MD, Rudnicka AR, Cook DG, Bush T, Stedman JR, et al. (2009). Chronic exposure to outdoor air pollution and markers of systemic inflammation. Epidemiology, 20, 245-53.
22. Franklin M, Schwartz J. (2008). The impact of secondary particles on the association between ambient ozone and mortality. Environ Health Perspect, 116, 453-8.
23. Goodman JE, Dodge DG, Bailey LA. (2010). A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. Regul Toxicol Pharmacol, 58, 308-22.
24. Goodman JE, Prueitt RL, Sax SN, Bailey LA, Rhomberg LR. (2013). Evaluation of the causal framework used for setting National Ambient Air Quality Standards. Crit Rev Toxicol, 43, 829-49.
25. Goodman JE, Prueitt RL, Sax SN, Lynch HN, Zu K, Lemay JC, et al. (2014). Weight-of-evidence evaluation of short-term cardiovascular effects of ozone. Crit Rev Toxicol, 44, 725-90.
26. Goodman M, Teta MJ, Hessel PA, Garabrant DH, Craven VA, Scrafford CG, Kelsh MA. (2004). Mesothelioma and lung cancer among motor vehicle mechanics: A meta-analysis. Ann Occup Hyg, 48, 309-26.
27. Gordon CJ, Jarema KA, Lehmann JR, Ledbetter AD, Schladweiler MC, Schmid JE, et al. (2013). Susceptibility of adult and senescent Brown Norway rats to repeated ozone exposure: An assessment of behavior, serum biochemistry and cardiopulmonary function. Inhal Toxicol, 25, 141-59.
28. Hatch GE, McKee J, Brown J, McDonnell W, Seal E, Soukup J, et al. (2013). Biomarkers of dose and effect of inhaled ozone in resting versus exercising human subjects: Comparison with resting rats. Biomark Insights, 8, 53-67.
29. Hatch GE, Slade R, Harris LP, McDonnell WF, Devlin RB, Koren HS, et al. (1994). Ozone dose and effect in humans and rats. A comparison using oxygen,-18 labeling and bronchoalveolar lavage. Am J Respir Crit Care Med, 150, 676-83.
30. Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al.; Cochrane Bias Methods Group, Cochrane Statistical Methods Group. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, d5928.
31. Hill AB. (1965). The environment and disease: Association or causation? Proc R Soc Med, 58, 295-300.
32. Hooijmans CR, Leenaars M, Ritskes-Hoitinga M. (2010). A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Altern Lab Anim, 38, 167-82.
33. Institute of Medicine (IOM). (2008). Improving the Presumptive Disability Decision-Making Process for Veterans. Committee on Evaluation of the Presumptive Disability Decision-Making Process for Veterans, Board on Military and Veterans Health, National Academies Press, Washington, DC. pp. 781. Available at http://books.nap.edu/openbook.php?record-id=11908 &
34. Ioannidis JP, Tzoulaki I. (2012). Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. Circ Res, 110, 658-62.
35. Jakobsen CJ, Torp P, Vester AE, Folkersen L, Thougaard A, Sloth E. (2010). Ketamine reduce left ventricular systolic and diastolic function in patients with ischaemic heart disease. Acta Anaesthesiol Scand, 54.
36. Janke K, Propper C, Henderson J. (2009). Do current levels of air pollution kill? The impact of air pollution on population mortality in England. Health Econ, 18, 1031-55.
37. Jerrett M, Burnett RT, Ma R, Pope CA, Krewski D, Newbold KB, et al. (2005). Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology, 16, 727-36.
38. Jerrett M, Burnett RT, Pope CA, Ito K, Thurston G, Krewski D, et al. (2009). Long-term ozone exposure and mortality. N Engl J Med, 360, 1085-95.
39. Katsouyanni K, Samet JM, Anderson HR, Atkinson R, Le Tertre A, Medina S, et al. (2009). Air Pollution and Health: A European and North American Approach (APHENA). HEI Research Report 142. Health Effects Institute, Boston, MA. pp. 132.
40. Khosravi A, Rao C, Naghavi M, Taylor R, Jafari N, Lopez AD. (2008). Impact of misclassification on measures of cardiovascular disease mortality in the Islamic Republic of Iran: A cross-sectional study. Bull World Health Org, 86, 688-96.
41. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. (2010). Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol, 8, e1000412.
42. th edition. McGraw-Hill Companies, Inc, pp. 1309.
43. Kodavanti UP, Thomas R, Ledbetter AD, Schladweiler MC, Shannahan JH, Wallenborn JG, et al. (2011). Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect, 119, 312-18.
44. Krewski D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, et al. (2009). Extended follow-up and spatial analysis of the American Cancer Society Study Linking Particulate Air Pollution and Mortality. HEI Research Report 140. Health Effects Institute, Boston, MA. pp. 154.
45. Lewington S, Bragg F, Clarke R. (2012). A review on metaanalysis of biomarkers: Promises and pitfalls. Clin Chem, 58, 1192-204.
46. Lipsett MJ, Ostro BD, Reynolds P, Goldberg D, Hertz A, Jerrett M, et al. (2011). Long-term exposure to air pollution and cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med, 184, 828-35.
47. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al.; American Heart Association Strategic Planning Task Force and Statistics Committee. (2010). Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation, 121, 586-613.
48. Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, et al. (2009). Reprint: Good laboratory practice: Preventing introduction of bias at the bench. J Cereb Blood Flow Metab, 29, 221-3.
49. Medinsky MA. (1996). Determinants of gas and vapor uptake in the respiratory tract. CIIT Activities, 16, 1-6.
50. Miller FJ. (1995). Uptake and fate of ozone in the respiratory tract. Toxicol Lett, 82-83, 277-85.
51. National Research Council (NRC), Committee on Tropospheric Ozone Formation and Measurement. (1991). Rethinking the Ozone Problem in Urban and Regional Air Pollution. Washington, DC: National Academy Press, pp. 523.
52. Nichols JL, Owens EO, Dutton SJ, Luben TJ. (2013). Systematic review of the effects of black carbon on cardiovascular disease among individuals with pre-existing disease. Int. J. Public Health, 58, 707-24.
53. Pascal M, Wagner V, Chatignoux E, Falq G, Corso M, Blanchard M, et al. (2012). Ozone and short-term mortality in nine French cities: Influence of temperature and season. Atmos Environ, 62, 566-72.
54. Perepu RS, Dostal DE, Garcia C, Kennedy RH, Sethi R. (2012). Cardiac dysfunction subsequent to chronic ozone exposure in rats. Mol Cell Biochem, 360, 339-45.
55. Perepu RS, Garcia C, Dostal D, Sethi R. (2010). Enhanced death signaling in ozone-exposed ischemic-reperfused hearts. Mol Cell Biochem, 336, 55-64.
56. Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. (2002). Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA, 287, 1132-41.
57. Rhomberg LR, Chandalia JK, Long CM, Goodman JE. (2011). Measurement error in environmental epidemiology and the shape of exposure-response curves. Crit Rev Toxicol, 41, 651-71.
58. Rhomberg LR, Goodman JE, Bailey LA, Prueitt RL, Beck NB, Bevan C, et al. (2013). A survey of frameworks for best practices in weight-of-evidence analyses. Crit Rev Toxicol, 43, 753-84.
59. Rothman KJ, Greenland S. (1998). Modern Epidemiology (Second Edition). Philadelphia: Lippincott Williams & Wilkins, pp. 738.
60. Rouslin W, Broge CW, Guerrieri F, Capozza G. (1995). ATPase activity, IF1 content, and proton conductivity of ESMP from control and ischemic slow and fast heart-rate hearts. J Bioenerg Biomembr, 27, 459-66.
61. Sarwar N, Thompson AJ, Di Angelantonio E. (2009). Markers of inflammation and risk of coronary heart disease. Dis Markers, 26, 217-25.
62. Sethi R, Manchanda S, Perepu RS, Kumar A, Garcia C, Kennedy RH, et al. (2012). Differential expression of caveolin-1 and caveolin-3: Potential marker for cardiac toxicity subsequent to chronic ozone inhalation. Mol Cell Biochem, 369, 9-15.
63. Smith KR, Jerrett M, Anderson HR, Burnett RT, Stone V, Derwent R, et al. (2009). Public health benefits of strategies to reduce greenhouse-gas emissions: Health implications of short-lived greenhouse pollutants. Lancet, 374, 2091-103.
64. Spencer-Hwang R, Knutsen SF, Soret S, Ghamsary M, Beeson WL, Oda K, et al. (2011). Ambient air pollutants and risk of fatal coronary heart disease among kidney transplant recipients. Am J Kidney Dis, 58, 608-16.
65. Tao Y, Huang W, Huang X, Zhong L, Lu SE, Li Y, et al. (2012). Estimated acute effects of ambient ozone and nitrogen dioxide on mortality in the Pearl River Delta of southern China. Environ Health Perspect, 120, 393-8.
66. Taubes G. (1995). Epidemiology faces its limits. Science, 269, 164-9.
67. US EPA (1998). Health Effects Test Guidelines: OPPTS 870.3465-90-Day Inhalation Toxicity. Office of Prevention, Pesticides and Toxic Substances, EPA, 712-C-98-204, pp. 17, August.
68. US EPA. (2006). Air Quality Criteria for Ozone and Related Photochemical Oxidants. Volume 1. Research Triangle Park, NC: Office of Research and Development, National Center for Environmental Assessment (NCEA), EPA, 600/R-05/004aF, pp. 821, February.
69. US EPA. (2013). Integrated Science Assessment for Ozone and Related Photochemical Oxidants (Final). National Center for Environmental Assessment (NCEA), EP, A/600/R-10/076F, pp. 1251, February.
70. US Public Health Service (USPHS). 2014. The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. Office of the Surgeon General. pp. 1440. http://www.surgeongeneral. gov/library/reports/50-years-of-progress/
71. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, Macleod MR. (2010). Can animal models of disease reliably inform human studies? PLoS Med, 7, e1000245.
72. Wang L, Yang G, Jiemin M, Rao C, Wan X, Dubrovsky G, Lopez AD. (2007). Evaluation of the quality of cause of death statistics in rural China using verbal autopsies. J Epidemiol Community Health, 61, 519-26.
73. Wang XY, Hu W, Tong S. (2009). Long-term exposure to gaseous air pollutants and cardio-respiratory mortality in Brisbane, Australia. Geospat Health, 3, 257-63.
74. Watkinson WP, Campen MJ, Nolan JP, Costa DL. (2001). Cardiovascular and systemic responses to inhaled pollutants in rodents: Effects of ozone and particulate matter. Environ Health Perspect, 109(Suppl 4), 539-46.
75. Watkinson WP, Campen MJ, Wichers LB, Nolan JP, Costa DL. (2003). Cardiac and thermoregulatory responses to inhaled pollutants in healthy and compromised rodents: Modulation via interaction with environmental factors. Environ Res, 92, 35-47.
76. Yang C, Yang H, Guo S, Wang Z, Xu X, Duan X, Kan H. (2012). Alternative ozone metrics and daily mortality in Suzhou: The China Air Pollution and Health Effects Study (CAPES). Sci Total Environ, 426, 83-9.
77. Zanobetti A, Schwartz J. (2011). Ozone and survival in four cohorts with potentially predisposing diseases. Am J Respir Crit Care Med, 184, 836-41.
78. Zhou X, Fragala MS, McElhaney JE, Kuchel GA. (2010). Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care, 13, 541-7.
79. Zile MR, Brutsaert DL. (2002). New concepts in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation, 105, 1387-93.